年間 6 号発行
ISSN 印刷: 1040-8401
ISSN オンライン: 2162-6472
Indexed in
Role of IL-10 Receptor Signaling in the Function of CD4+ T-Regulatory Type 1 cells: T-Cell Therapy in Patients with Inflammatory Bowel Disease
要約
Inflammatory bowel disease (IBD) is caused by the interplay of various factors. It occurs in genetically susceptible people due to dysregulated immune responses to several unknown antigens, including those derived from the commensal microbiota. Effector T-helper cells, especially TH17 cells, are considered a major driver of disease progression. The endogenous resident counterparts of effector T-helper cells are the regulatory T cells, mainly Foxp3+ Treg cells and type 1 regulatory (TR1) T cells. Both have strong immune regulatory capacity and can terminate immune responses. Interestingly, the expression of IL-10 receptor on regulatory T cells has a high impact on the regulatory capacity of these cells. Inflammatory bowel disease is becoming a global health issue. No curative therapy is currently available. However, initial clinical trials have been conducted successfully, proving the safety of a regulatory T-cell–based therapy. This therapy might lead to long-lasting remission and to a possible cure for IBD. This review provides a summary of the current findings and the outcome of the clinical trials based on T-cell therapy for IBD and for other inflammatory conditions.
-
Rosa Degasperi Giovanna, Mucosal Immunology in the Inflammatory Bowel Diseases, in Biological Therapy for Inflammatory Bowel Disease, 2020. Crossref
-
Yasueda Asuka, Kayama Hisako, Murohashi Michiko, Nishimura Junichi, Wakame Koji, Komatsu Ken-ichi, Ogino Takayuki, Miyoshi Norikatsu, Takahashi Hidekazu, Uemura Mamoru, Matsuda Chu, Kitagawa Toru, Takeda Kiyoshi, Ito Toshinori, Doki Yuichiro, Eguchi Hidetoshi, Shimizu Shigeomi, Mizushima Tsunekazu, Sanguisorba officinalis L. derived from herbal medicine prevents intestinal inflammation by inducing autophagy in macrophages, Scientific Reports, 10, 1, 2020. Crossref
-
Magrone Thea, Magrone Manrico, Jirillo Emilio, Mast Cells as a Double-Edged Sword in Immunity: Their Function in Health and Disease. First of Two Parts, Endocrine, Metabolic & Immune Disorders - Drug Targets, 20, 5, 2020. Crossref
-
Pinto-Sanchez Maria Ines, Seiler Caroline L., Santesso Nancy, Alaedini Armin, Semrad Carol, Lee Anne R., Bercik Premysl, Lebwohl Benjamin, Leffler Daniel A., Kelly Ciaran P., Moayyedi Paul, Green Peter H., Verdu Elena F., Association Between Inflammatory Bowel Diseases and Celiac Disease: A Systematic Review and Meta-Analysis, Gastroenterology, 159, 3, 2020. Crossref
-
Ohya Susumu, Matsui Miki, Kajikuri Junko, Endo Kyoko, Kito Hiroaki, Increased Interleukin-10 Expression by the Inhibition of Ca2+-Activated K+ Channel KCa3.1 in CD4+CD25+ Regulatory T Cells in the Recovery Phase in an Inflammatory Bowel Disease Mouse Model, Journal of Pharmacology and Experimental Therapeutics, 377, 1, 2021. Crossref
-
Yu Qing, Dysregulation of Adaptive Immunity in Sjögren’s Syndrome, in Sjögren's Syndrome and Oral Health, 2021. Crossref
-
Yogev Nir, Bedke Tanja, Kobayashi Yasushi, Brockmann Leonie, Lukas Dominika, Regen Tommy, Croxford Andrew L., Nikolav Alexei, Hövelmeyer Nadine, von Stebut Esther, Prinz Marco, Ubeda Carles, Maloy Kevin J., Gagliani Nicola, Flavell Richard A., Waisman Ari, Huber Samuel, CD4+ T-cell-derived IL-10 promotes CNS inflammation in mice by sustaining effector T cell survival, Cell Reports, 38, 13, 2022. Crossref